204 related articles for article (PubMed ID: 24818166)
21. Radioimmunodetection and radioimmunotherapy of head and neck cancer.
Börjesson PK; Postema EJ; de Bree R; Roos JC; Leemans CR; Kairemo KJ; van Dongen GA
Oral Oncol; 2004 Sep; 40(8):761-72. PubMed ID: 15288829
[TBL] [Abstract][Full Text] [Related]
22. Therapy and imaging of pancreatic carcinoma xenografts with radioiodine-labeled chimeric monoclonal antibody A10 and its Fab fragment.
Kamigaki T; Yamamoto M; Ohyanagi H; Ohya M; Shimazoe T; Kono A; Ohtani W; Narita Y; Ohkubo M; Saitoh Y
Jpn J Cancer Res; 1995 Dec; 86(12):1216-23. PubMed ID: 8636013
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of novel highly specific antibodies to cancer testis antigen Centrin-1 for radioimmunoimaging and radioimmunotherapy of pancreatic cancer.
Jiao R; Allen KJH; Malo ME; Helal M; Jiang Z; Smart K; Buhl SV; Rickles D; Bryan RA; Dadachova E
Cancer Med; 2019 Sep; 8(11):5289-5300. PubMed ID: 31309741
[TBL] [Abstract][Full Text] [Related]
24. [Immunoscintigraphy and radioimmunotherapy of cancer using monoclonal antibodies].
Oriuchi N
Gan To Kagaku Ryoho; 1999 May; 26(6):762-7. PubMed ID: 10410144
[TBL] [Abstract][Full Text] [Related]
25. Detection of early-stage pancreatic adenocarcinoma.
Gold DV; Goggins M; Modrak DE; Newsome G; Liu M; Shi C; Hruban RH; Goldenberg DM
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2786-94. PubMed ID: 20810605
[TBL] [Abstract][Full Text] [Related]
26. Combined 90Yttrium-DOTA-labeled PAM4 antibody radioimmunotherapy and gemcitabine radiosensitization for the treatment of a human pancreatic cancer xenograft.
Gold DV; Modrak DE; Schutsky K; Cardillo TM
Int J Cancer; 2004 Apr; 109(4):618-26. PubMed ID: 14991585
[TBL] [Abstract][Full Text] [Related]
27. A new radiopharmaceutical compound (131I-PR81) for radioimmunotherapy of breast cancer: labeling of antibody and its quality control.
Mohammadnejad J; Rasaee MJ; Babaei MH; Paknejad M; Zahir MH; Salouti M; Rajabi AB; Mazidi M
Hum Antibodies; 2010; 19(4):79-88. PubMed ID: 21178279
[TBL] [Abstract][Full Text] [Related]
28. Radioimmunotherapy for pancreatic carcinoma using (131)I-labeled monoclonal antibody Nd2 in xenografted nude mice.
Inui A; Chung YS; Sawada T; Kondo Y; Ho JJ; Kim YS; Sowa M
Jpn J Cancer Res; 1996 Sep; 87(9):977-84. PubMed ID: 8878462
[TBL] [Abstract][Full Text] [Related]
29. PAM4 enzyme immunoassay alone and in combination with CA 19-9 for the detection of pancreatic adenocarcinoma.
Gold DV; Gaedcke J; Ghadimi BM; Goggins M; Hruban RH; Liu M; Newsome G; Goldenberg DM
Cancer; 2013 Feb; 119(3):522-8. PubMed ID: 22898932
[TBL] [Abstract][Full Text] [Related]
30. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
[TBL] [Abstract][Full Text] [Related]
31. Targeting of xenografted pancreatic cancer with a new monoclonal antibody, PAM4.
Gold DV; Alisauskas R; Sharkey RM
Cancer Res; 1995 Mar; 55(5):1105-10. PubMed ID: 7866995
[TBL] [Abstract][Full Text] [Related]
32. Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.
Behr TM; Sharkey RM; Juweid MI; Dunn RM; Ying Z; Zhang CH; Siegel JA; Gold DV; Goldenberg DM
Cancer Res; 1996 Apr; 56(8):1805-16. PubMed ID: 8620497
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibodies used in the detection and treatment of epithelial ovarian cancer.
Muto MG; Kassis AI
Cancer; 1995 Nov; 76(10 Suppl):2016-27. PubMed ID: 8634994
[TBL] [Abstract][Full Text] [Related]
34. Carcinoembryonic antigen as a target cancer antigen for radiolabeled antibodies: prospects for cancer imaging and therapy.
Goldenberg DM
Tumour Biol; 1995; 16(1):62-73. PubMed ID: 7863224
[TBL] [Abstract][Full Text] [Related]
35. CaNa2EDTA for improvement of radioimmunodetection and radioimmunotherapy with 111In and 90Y-DTPA-anti-CEA MAbs in nude mice bearing human colorectal cancer.
Watanabe N; Oriuchi N; Endo K; Inoue T; Kuroki M; Matsuoka Y; Tanada S; Murata H; Kim EE; Sasaki Y
J Nucl Med; 2000 Feb; 41(2):337-44. PubMed ID: 10688120
[TBL] [Abstract][Full Text] [Related]
36. Radioimmunodetection and radioimmunotherapy of malignant melanoma. A review.
Liewendahl K; Pyrhönen S
Acta Oncol; 1993; 32(7-8):717-21. PubMed ID: 8305217
[TBL] [Abstract][Full Text] [Related]
37. Tumor pretargeting for radioimmunodetection and radioimmunotherapy.
Zhu H; Jain RK; Baxter LT
J Nucl Med; 1998 Jan; 39(1):65-76. PubMed ID: 9443740
[TBL] [Abstract][Full Text] [Related]
38. Clinical utility of radiolabeled monoclonal antibodies in prostate cancer.
David KA; Milowsky MI; Kostakoglu L; Vallabhajosula S; Goldsmith SJ; Nanus DM; Bander NH
Clin Genitourin Cancer; 2006 Mar; 4(4):249-56. PubMed ID: 16729907
[TBL] [Abstract][Full Text] [Related]
39. Imaging and therapy with monoclonal antibodies in non-hematopoietic tumors.
Mach JP; Pèlegrin A; Buchegger F
Curr Opin Immunol; 1991 Oct; 3(5):685-93. PubMed ID: 1755986
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
